Artelo Biosciences closes $2M public offering of common stock and pre-funded warrants

ARTELO BIOSCIENCES, INC.

Gross proceeds ~$2M from 441,210 shares at $4.40/share and 13,335 pre-funded warrants at $4.399/warrant (ex. price $0.001).
Underwriter R.F. Lafferty has 45-day option to purchase up to additional 68,181 shares/warrants for overallotments.
Net proceeds will advance preclinical/clinical development, manufacturing, and working capital needs.
Directors, officers subject to 30-day lock-up; company granted R.F. Lafferty right of first refusal through Dec 31, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.